Compare CVS Health Corp (CVS) vs Quantum Computing Inc (QUBT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Quantum Computing Inc — how do they compare? CVS Health Corp trades at $93.66 (market cap $122.36B), while Quantum Computing Inc trades at $8.98 (market cap $2.07B). The key difference: CVS Health Corp is far larger — about 59.1× Quantum Computing Inc's market cap, and CVS Health Corp pays a 2.78% dividend while Quantum Computing Inc pays none. Which is the better fit depends on your goals.
| CVS | QUBT | |
|---|---|---|
Market Cap | $122.36B | $2.07B |
Sector | Health | Technology |
52-Week High | $110.60 | $24.62 |
52-Week Low | $65.51 | $6.31 |
Enterprise Value | $184.71B | $1.09B |
Dividend Yield | 2.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.
The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.
QUBT trades at $9.18, up 4.62% today, amid a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $5.6 million, a significant increase from the prior year, but posted a net loss. Analyst consensus is strongly bullish with a $21.33 price target, though high valuation multiples and negative margins highlight financial challenges. Recent news includes the strategic acquisition of NHanced Semiconductors, expanding manufacturing capabilities.
The outlook is speculative with substantial growth potential in quantum computing, but high execution risk persists. Investment appeal hinges on commercial traction and margin improvement, while risks include cash burn, competitive pressures, and ongoing losses. The stock offers high upside if execution succeeds, but volatility is expected.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Quantum Computing Inc
Quantum Computing Inc. is a company focused on providing accessible quantum computing and quantum-enhanced software solutions for complex problems. The company's technology is designed to run on both classical and quantum hardware, enabling businesses to explore the power of quantum computing today for applications in finance, drug discovery, and logistics. QUBT offers a platform that makes quantum algorithms and software available through the cloud, aiming to democratize access to this advanced computing paradigm.
Read more on QUBT →
